Skip to main content

Biomea Fusion, Inc.

BMEA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001840439

No open-market purchases or sales by Biomea Fusion, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Biomea Fusion, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of BMEA: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders8773−14
Shares28.7M25.1M−3.68M (−12.8%)
Value$51.7M$50.6M−$1.11M (−2.1%)

New holders (11)

Institutions that held Biomea Fusion, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to BMEA in Q3 2025
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC595,900$1.20M0.00%
Mariner, LLC238,930$482.6K0.00%
Citadel Advisors LLC179,825$363.2K0.00%
Quadrature Capital Ltd88,262$179.6K0.00%
Virtu Financial LLC19,061$39.0K0.00%
JustInvest LLC16,044$32.4K0.00%
Scientech Research LLC12,207$24.7K0.01%
Qube Research & Technologies Ltd10,032$20.3K0.00%
Rockefeller Capital Management L.P.2,000$4.04K0.00%
Fortitude Family Office, LLC296$5980.00%
MAI Capital Management100$2020.00%

Sold out (25)

Institutions that held Biomea Fusion, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.